The European Commission has proposed an ambitious package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the health sector.
The package includes a Biotech Act, revised rules for medical devices, and a Safe Hearts Plan, which will:
- strengthen the EU biotechnology sector;
- accelerate the development of innovative new treatments and therapies for patients;
- make rules for the development of medical devices from lab to market simpler and more efficient for EU companies, while ensuring a very high level of patient safety;
- tackle Europe's leading cause of death, cardiovascular diseases, with a comprehensive EU approach to prevent, detect, and treat them in time....
[European Commission - Press release]
